Impact of the Extent of Lymph Node Dissection on Survival Outcomes in Clinically Lymph Node-Positive Bladder Cancer.

Markus von DeimlingMarc A Furrer Laura S Mertens Andrea MariNoor van GinkelMara BacchianiMoritz MaasRenate Pichler Roger Li Marco MoschiniAlberto BianchiMalte W VetterleinChiara LonatiFelice CrocettoJacob TaylorKarl H Tully Luca Afferi Shahrokh F Shariat Francesco Del GiudiceMattia LongoniEkaterina LaukhtinaAlessandro AntonelliMichael RinkMargit FischYair LotanPhilippe E SpiessPeter C BlackBernhard KissBenjamin PradereShahrokh F Shariatnull null

Published in: BJU international (2023)

Performing an ePLND at the time of RC in cN+ patients improved neither RFS nor OS compared to sPLND, regardless of the induction chemotherapy status. Pretreatment risk stratification is paramount to identify ideal candidates for RC with ePLND as part of a multimodal treatment approach.

Keyphrases

lymph node
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
sentinel lymph node
prognostic factors
peritoneal dialysis
rectal cancer
squamous cell carcinoma
prostate cancer
patient reported outcomes
lymph node metastasis
early stage
locally advanced
chronic pain
minimally invasive